← Back to Clinical Trials
Recruiting NCT04033679

The Effects of Non-invasive Brain Stimulation on Treatment Adherence in Schizophrenia

Trial Parameters

Condition Schizophrenia;Schizoaffective
Sponsor Centre for Addiction and Mental Health
Study Type INTERVENTIONAL
Phase N/A
Enrollment 106
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2019-08-15
Completion 2026-03-31
Interventions
Active TDCSSham TDCS

Brief Summary

This study seeks to explore the effects of transcranial direct current stimulation (tDCS), a non-invasive method of brain stimulation, as an adjunctive treatment to improve antipsychotic medication adherence in patients with schizophrenia (SCZ). The investigators hypothesize that 20 sessions of tDCS will improve medication nonadherence in patients with SCZ.

Eligibility Criteria

Inclusion Criteria: 1. Male or female participants of any race or ethnicity 2. Inpatients or outpatients ≥18 years of age 3. DSM-V diagnosis of SCZ or schizoaffective disorder 4. Capable of consenting to participate in the research study 5. On a stable dose of antipsychotic drug and other concomitant medications for at least 2 months, and unlikely to undergo changes in dose during the study Exclusion Criteria: 1. Unwilling or incapable to consent to the study based on the MacArthur Test of Competence 2. Unstable medical or any concomitant major medical or neurological illness, including a history of seizures 3. Acute suicidal or homicidal ideation 4. Formal thought disorder rating ≥3 on the Positive and Negative Syndrome Scale (PANSS) P2 conceptual disorganization item 5. DSM-V substance dependence (except caffeine and nicotine) within 1 month of entering the study\* 6. Positive urine drug screen except for cannabis/marijuana at the screening visit 7. Metal implants or pacemaker preclu

Related Trials